IVA
Inventiva S.A. Healthcare - Biotechnology Investor Relations →
Inventiva S.A. (IVA) closed at $5.88 as of 2026-02-02, trading 41.4% above its 200-week moving average of $4.16. The stock is currently moving closer to the line, down from 47.2% last week. The 14-week RSI sits at 64, indicating neutral momentum.
Over the past 243 weeks of data, IVA has crossed below its 200-week moving average 6 times. On average, these episodes lasted 35 weeks. The average one-year return after crossing below was -59.6%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1221 million, IVA is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. The stock trades at -78.0x book value.
Share count has increased 134.0% over three years, indicating dilution.
Over the past 4.8 years, a hypothetical investment of $100 in IVA would have grown to $41, compared to $172 for the S&P 500. IVA has returned -17.0% annualized vs 12.1% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: IVA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After IVA Crosses Below the Line?
Across 6 historical episodes, buying IVA when it crossed below its 200-week moving average produced an average return of -65.0% after 12 months (median -64.0%), compared to -9.2% for the S&P 500 over the same periods. After 24 months, the average return was -71.5% vs +4.0% for the index.
Each line shows $100 invested at the moment IVA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
IVA has crossed below its 200-week MA 6 times with an average 1-year return of +-59.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 2021 | Aug 2021 | 5 | 19.6% | -64.3% | -56.2% |
| Oct 2021 | Oct 2021 | 2 | 4.7% | -45.1% | -54.2% |
| Nov 2021 | Nov 2021 | 2 | 2.4% | -66.7% | -55.5% |
| Jan 2022 | Aug 2025 | 190 | 76.0% | -62.1% | -54.1% |
| Oct 2025 | Oct 2025 | 1 | 4.9% | N/A | +29.2% |
| Oct 2025 | Dec 2025 | 8 | 13.1% | N/A | +36.7% |
| Average | 35 | — | +-59.6% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02